This Comment proposes the use of a specifically tailored obviousness standard as a new solution to the IT and pharmaceutical patent industries' divergent needs. Part I summarizes the obviousness standard's history in patent law. Part II illustrates how the IT and pharmaceutical industries have divergent needs. Part III describes why using a single standard for the obviousness inquiry is inadequate to meet the needs of both the IT and pharmaceutical industries. Part IV illustrates why the obviousness standard needs to be specifically tailored for the IT and pharmaceutical industries. Finally, Part V concludes that a dual standard for obviousness is needed to effectively address the IT and pharmaceutical industries' needs.
Patently Obvious: A Dual Standard Solution to the Diverging Needs of the Information Technology and Pharmaceutical Patent Industries, 39 Golden Gate U. L. Rev.